{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T01:32:12Z","timestamp":1778117532353,"version":"3.51.4"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T00:00:00Z","timestamp":1742342400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Non-tuberculous mycobacteria (NTM) are widespread environmental pathogens that can lead to significant disease burden, particularly in immunocompromised individuals, but also in those with a normal immune system. The global incidence of NTM is increasing rapidly, with <jats:italic>Mycobacterium avium<\/jats:italic> complex (MAC) being one of the most common types. The immunopathogenesis of the MAC involves a complex interaction between the bacteria and the host immune system. MAC survives and replicates within macrophages by preventing the fusion of phagosomes and lysosomes. The mycobacteria can neutralize reactive oxygen and nitrogen species produced by the macrophages through their own enzymes. Additionally, MAC modulates cytokine production, allowing it to suppress or regulate the immune response. Diagnosing MAC infections can be challenging, and the effectiveness of available treatments may be limited due to MAC\u2019s unpredictable resistance to various antimycobacterial drugs in different regions. Treating MAC infection requires a collaborative approach involving different healthcare professionals and ensuring patient compliance. This review aims to shed light on the complexities of MAC infection treatment, discussing the challenges of MAC infection diagnosis, pharmacological considerations, such as drug regimens, drug monitoring, drug interactions, and the crucial role of a multidisciplinary healthcare team in achieving the best possible treatment outcomes for patients.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1554544","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:07:58Z","timestamp":1742368078000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Recent advances in immunopathogenesis and clinical practice: mastering the challenge-managing of non-tuberculous mycobacteria"],"prefix":"10.3389","volume":"16","author":[{"given":"Wiwat","family":"Chancharoenthana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supitcha","family":"Kamolratanakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suwatchareeporn","family":"Rotcheewaphan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asada","family":"Leelahavanichkul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus J.","family":"Schultz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.meegid.2017.10.013","article-title":"The new phylogeny of the genus Mycobacterium: the old and the news","volume":"56","author":"Tortoli","year":"2017","journal-title":"Infect Genet Evol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)34193-1","article-title":"Anonymous mycobacteria in pulmonary disease","volume":"43","author":"Runyon","year":"1959","journal-title":"Med Clin North Am"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.14.0120","article-title":"The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review","volume":"18","author":"Brode","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"B5","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1164\/ajrccm\/139.1.4","article-title":"The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS)","volume":"139","author":"Horsburgh","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1086\/cid.2000.30.issue-s1","article-title":"Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy","author":"Kaplan","year":"2000","journal-title":"Clin Infect Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.2.566","article-title":"Mycobacterium avium complex pulmonary disease in patients without HIV infection","volume":"126","author":"Field","year":"2004","journal-title":"Chest"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/QAD.0000000000000239","article-title":"Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines","author":"Nelson","year":"2014","journal-title":"AIDS"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198909283211304","article-title":"Infection with Mycobacterium avium complex in patients without predisposing conditions","volume":"321","author":"Prince","year":"1989","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1590\/S1413-86702005000200009","article-title":"Infection with the Mycobacterium avium complex in patients without predisposing conditions: a case report and literature review","volume":"9","author":"Martins","year":"2005","journal-title":"Braz J Infect Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00114004","article-title":"Nontuberculous mycobacteria in non-HIV patients: epidemiology, treatment and response","volume":"23","author":"Henry","year":"2004","journal-title":"Eur Respir J"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1111160","article-title":"Adult-onset immunodeficiency in Thailand and Taiwan","volume":"367","author":"Browne","year":"2012","journal-title":"N Engl J Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0027-2016","article-title":"Rapidly growing mycobacteria","volume":"5","author":"Brown-Elliott","year":"2017","journal-title":"Microbiol Spectr"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.TNMI7-0045-2017","article-title":"Mycobacterium avium complex disease","volume":"5","author":"Daley","year":"2017","journal-title":"Microbiol Spectr"},{"key":"B16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","article-title":"Natural history and evolution of anti-interferon-\u03b3 autoantibody-associated immunodeficiency syndrome in Thailand and the United States","volume":"71","author":"Hong","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100244","DOI":"10.1016\/j.jctube.2021.100244","article-title":"Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease","volume":"24","author":"Pennington","year":"2021","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2023.05.013","article-title":"Clinical characteristics of extrapulmonary nontuberculous mycobacteria infections in comparison with pulmonary infections: A single-center, retrospective study in Japan","volume":"29","author":"Omori","year":"2023","journal-title":"J Infect Chemother"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/165.6.1082","article-title":"Incidence of Mycobacterium avium-intracellulare complex bacteremia in human immunodeficiency virus-positive patients","volume":"165","author":"Nightingale","year":"1992","journal-title":"J Infect Dis"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2020.05.001","article-title":"Host immune response against environmental nontuberculous mycobacteria and the risk populations of nontuberculous mycobacterial lung disease","author":"Shu","year":"2020","journal-title":"J Formos Med Assoc"},{"key":"B21","doi-asserted-by":"publisher","first-page":"90","DOI":"10.3390\/microorganisms7030090","article-title":"Mycobacterium abscessus: environmental bacterium turned clinical nightmare","volume":"7","author":"Lopeman","year":"2019","journal-title":"Microorganisms"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00149212","article-title":"The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study","volume":"42","author":"Hoefsloot","year":"2013","journal-title":"Eur Respir J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"a018424","DOI":"10.1101\/cshperspect.a018424","article-title":"Innate and adaptive cellular immune responses to Mycobacterium tuberculosis infection","volume":"5","author":"Mayer-Barber","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"B24","first-page":"52","article-title":"Airborne infectious microorganisms","author":"Gonzalez-Martin","year":"2019","journal-title":"Encyclopedia Microbiol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1128\/iai.59.5.1697-1702.1991","article-title":"Interaction of Mycobacterium avium complex with human macrophages: roles of membrane receptors and serum proteins","volume":"59","author":"Bermudez","year":"1991","journal-title":"Infect Immun"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.2.663-670.1993","article-title":"Mycobacterium avium-M. intracellulare binds to the integrin receptor alpha v beta 3 on human monocytes and monocyte-derived macrophages","volume":"61","author":"Rao","year":"1993","journal-title":"Infect Immun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.11.4720-4725.1992","article-title":"Activity of defensins from human neutrophilic granulocytes against Mycobacterium avium-Mycobacterium intracellulare","volume":"60","author":"Ogata","year":"1992","journal-title":"Infect Immun"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01368","article-title":"Control of phagocytosis by microbial pathogens","volume":"8","author":"Uribe-Querol","year":"2017","journal-title":"Front Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7555\/JBR.36.20220007","article-title":"Characteristics of alveolar macrophages in bronchioalveolar lavage fluids from active tuberculosis patients identified by single-cell RNA sequencing","volume":"36","author":"Chen","year":"2022","journal-title":"J BioMed Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.6.3786","article-title":"IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille calmette-guerin infection","volume":"178","author":"Umemura","year":"2007","journal-title":"J Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00820-13","article-title":"Mycobacterium avium biofilm attenuates mononuclear phagocyte function by triggering hyperstimulation and apoptosis during early infection","volume":"82","author":"Rose","year":"2014","journal-title":"Infect Immun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0241TR","article-title":"Macrophage signaling pathways in pulmonary nontuberculous mycobacteria infections","volume":"63","author":"Prasla","year":"2020","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00120","article-title":"The role of the innate immune system in granulomatous disorders","volume":"4","author":"Petersen","year":"2013","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jctube.2017.02.001","article-title":"Histopathologic review of granulomatous inflammation","volume":"7","author":"Shah","year":"2017","journal-title":"J Clin Tuberc Other Mycobact Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00491","article-title":"Macrophage cytokines: involvement in immunity and infectious diseases","volume":"5","author":"Arango Duque","year":"2014","journal-title":"Front Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"3816","DOI":"10.1038\/s41467-021-24127-3","article-title":"Intracellular localisation of Mycobacterium tuberculosis affects efficacy of the antibiotic pyrazinamide","volume":"12","author":"Santucci","year":"2021","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.58.6.704","article-title":"The role of tumor necrosis factor, interferon-gamma, transforming growth factor-beta, and nitric oxide in the expression of immunosuppressive functions of splenic macrophages induced by Mycobacterium avium complex infection","volume":"58","author":"Tomioka","year":"1995","journal-title":"J Leukoc Biol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(04)01203-4","article-title":"Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae","volume":"4","author":"van de Vosse","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.11.036","article-title":"Two novel STAT1 mutations cause Mendelian susceptibility to mycobacterial disease","volume":"591","author":"Liu","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.931876","article-title":"Modulating macrophage function to reinforce host innate resistance against Mycobacterium avium complex infection","volume":"13","author":"Park","year":"2022","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s10875-013-9882-5","article-title":"Interferon alpha treatment of patients with impaired interferon gamma signaling","volume":"33","author":"Bax","year":"2013","journal-title":"J Clin Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1128\/iai.61.7.3093-3097.1993","article-title":"Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice","volume":"61","author":"Bermudez","year":"1993","journal-title":"Infect Immun"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00548-2020","article-title":"Subtle immunodeficiencies in nodular-bronchiectatic Mycobacterium avium complex lung disease","volume":"6","author":"Bruno","year":"2020","journal-title":"ERJ Open Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2019.03081","article-title":"Proteomic profiling reveals the architecture of granulomatous lesions caused by tuberculosis and Mycobacterium avium complex lung disease","volume":"10","author":"Seto","year":"2020","journal-title":"Front Microbiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.01549-07","article-title":"Incorporation of Mycobacterium tuberculosis lipoarabinomannan into macrophage membrane rafts is a prerequisite for the phagosomal maturation block","volume":"76","author":"Welin","year":"2008","journal-title":"Infect Immun"},{"key":"B47","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.cellimm.2012.02.009","article-title":"Mycobacterium tuberculosis ManLAM inhibits T-cell-receptor signaling by interference with ZAP-70, Lck and LAT phosphorylation","volume":"275","author":"Mahon","year":"2012","journal-title":"Cell Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001224","article-title":"The rough colony morphotype of Mycobacterium avium exhibits high virulence in human macrophages and mice","volume":"69","author":"Nishimura","year":"2020","journal-title":"J Med Microbiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe068122","article-title":"Marfan\u2019s syndrome and related disorders\u2013more tightly connected than we thought","volume":"355","author":"Gelb","year":"2006","journal-title":"N Engl J Med"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.13.0763","article-title":"The prevalence of bronchiectasis in patients with Marfan syndrome","volume":"18","author":"Hwang","year":"2014","journal-title":"Int J Tuberc Lung Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112147-20230928-00203","article-title":"Secondary non-tuberculous mycobacterium infection in patients with bronchiectasis caused by Marfan syndrome","volume":"47","author":"Li","year":"2024","journal-title":"Zhonghua Jie He Hu Xi Za Zhi"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.11.0301","article-title":"Pulmonary non-tuberculous mycobacterial infection in congenital contractural arachnodactyly","volume":"16","author":"Paulson","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20140280","article-title":"Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome","volume":"212","author":"Kreins","year":"2015","journal-title":"J Exp Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00148604","article-title":"Sentinel-site surveillance of Mycobacterium avium complex pulmonary disease","volume":"26","author":"Maugein","year":"2005","journal-title":"Eur Respir J"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1086\/jid.2001.183.issue-3","article-title":"Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex","volume":"183","author":"Vankayalapati","year":"2001","journal-title":"J Infect Dis"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(02)01313-X","article-title":"Profound interferon gamma deficiency in patients with chronic pulmonary nontuberculous mycobacteriosis","volume":"113","author":"Safdar","year":"2002","journal-title":"Am J Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1016038","article-title":"T-cell deficiency and hyperinflammatory monocyte responses associate with Mycobacterium avium complex lung disease","volume":"13","author":"Lindestam Arlehamn","year":"2022","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201502-0387OC","article-title":"Pulmonary nontuberculous mycobacterial infection. A multisystem, multigenic disease","volume":"192","author":"Szymanski","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201612-2479OC","article-title":"Whole-exome sequencing identifies the 6q12-q16 linkage region and a candidate gene, TTK, for pulmonary nontuberculous mycobacterial disease","volume":"196","author":"Chen","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200207-679OC","article-title":"Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease","volume":"167","author":"Oliver","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"B61","article-title":"Pulmonary Mycobacterium avium complex infection associated with the IVS8-T5 allele of the CFTR gene","volume":"11","author":"Mai","year":"2007","journal-title":"Int J Tuberc Lung Dis"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202209-1653OC","article-title":"Genetic modifiers of cystic fibrosis lung disease severity: whole-genome analysis of 7,840 patients","volume":"207","author":"Zhou","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1902269","DOI":"10.1183\/13993003.02269-2019","article-title":"Genome-wide association study in patients with pulmonary Mycobacterium avium complex disease","volume":"58","author":"Namkoong","year":"2021","journal-title":"Eur Respir J"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/sj.emboj.7601145","article-title":"Crystal structure of CHP2 complexed with NHE1-cytosolic region and an implication for pH regulation","volume":"25","author":"Ammar","year":"2006","journal-title":"EMBO J"},{"key":"B65","article-title":"Molecular epidemiological analysis by IS1245-based restriction fragment length polymorphism typing on cases with pulmonary Mycobacterium avium disease observed in the same family","volume":"79","author":"Kuwabara","year":"2004","journal-title":"Kekkaku"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1173","article-title":"Familial clustering of pulmonary nontuberculous mycobacterial disease","volume":"137","author":"Colombo","year":"2010","journal-title":"Chest"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2023.097","article-title":"Alterations in lung and gut microbiota reduce diversity in patients with nontuberculous mycobacterial pulmonary disease","volume":"38","author":"Choi","year":"2023","journal-title":"Korean J Intern Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.940935","article-title":"Critical roles of sepsis-reshaped fecal virota in attenuating sepsis severity","volume":"13","author":"Chancharoenthana","year":"2022","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00009","article-title":"The gut-lung axis in health and respiratory diseases: a place for inter-organ and inter-kingdom crosstalks","volume":"10","author":"Enaud","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/nrmicro2259","article-title":"Bacterial competition: surviving and thriving in the microbial jungle","volume":"8","author":"Hibbing","year":"2010","journal-title":"Nat Rev Microbiol"},{"key":"B71","doi-asserted-by":"publisher","first-page":"9345","DOI":"10.1038\/s41598-022-13098-0","article-title":"Macrophage depletion alters bacterial gut microbiota partly through fungal overgrowth in feces that worsens cecal ligation and puncture sepsis mice","volume":"12","author":"Hiengrach","year":"2022","journal-title":"Sci Rep"},{"key":"B72","doi-asserted-by":"publisher","first-page":"2073132","DOI":"10.1080\/19490976.2022.2073132","article-title":"Arginine-mediated gut microbiome remodeling promotes host pulmonary immune defense against nontuberculous mycobacterial infection","volume":"14","author":"Kim","year":"2022","journal-title":"Gut Microbes"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-019-05581-y","article-title":"Gut leakage of fungal-derived inflammatory mediators: part of a gut-liver-kidney axis in bacterial sepsis","volume":"64","author":"Amornphimoltham","year":"2019","journal-title":"Dig Dis Sci"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0206079","article-title":"Macrophage nutriprive antimicrobial mechanisms","volume":"79","author":"Appelberg","year":"2006","journal-title":"J Leukoc Biol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1711.2000.00933.x","article-title":"Restraining mycobacteria: role of granulomas in mycobacterial infections","volume":"78","author":"Saunders","year":"2000","journal-title":"Immunol Cell Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2001.00150.x","article-title":"SLC11A1 (formerly NRAMP1) and disease resistance","volume":"3","author":"Blackwell","year":"2001","journal-title":"Cell Microbiol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.8.2923-2929.1996","article-title":"The Bcg\/Ity\/Lsh locus: genetic transfer of resistance to infections in C57BL\/6J mice transgenic for the Nramp1 Gly169 allele","volume":"64","author":"Govoni","year":"1996","journal-title":"Infect Immun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1128\/iai.60.1.150-153.1992","article-title":"T-cell immune responses in Mycobacterium avium-infected mice","volume":"60","author":"Hubbard","year":"1992","journal-title":"Infect Immun"},{"key":"B79","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/S1521-6616(03)00210-9","article-title":"The immunological aspects of latency in tuberculosis","volume":"110","author":"Chan","year":"2004","journal-title":"Clin Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.38.12.2717","article-title":"Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice","volume":"38","author":"Bermudez","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2016.31.5.649","article-title":"Diagnosis and treatment of nontuberculous mycobacterial lung disease","volume":"31","author":"Kwon","year":"2016","journal-title":"J Korean Med Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1146\/annurev.immunol.19.1.93","article-title":"Immunology of tuberculosis","volume":"19","author":"Flynn","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2008.11.014","article-title":"The role of the granuloma in expansion and dissemination of early tuberculous infection","volume":"136","author":"Davis","year":"2009","journal-title":"Cell"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2005.00667.x","article-title":"The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells","volume":"8","author":"Yamazaki","year":"2006","journal-title":"Cell Microbiol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.71.10.5831-5844.2003","article-title":"Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection","volume":"71","author":"Capuano","year":"2003","journal-title":"Infect Immun"},{"key":"B86","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS\/ERS\/ESCMID\/IDSA clinical practice guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.5999\/aps.2014.41.6.759","article-title":"Empirical treatment of highly suspected nontuberculous mycobacteria infections following aesthetic procedures","volume":"41","author":"Kim","year":"2014","journal-title":"Arch Plast Surg"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.31.5.1376-1378.1993","article-title":"Conventional identification characteristics, mycolate and fatty acid composition, and clinical significance of MAIX AccuProbe-positive isolates of Mycobacterium avium complex","volume":"31","author":"Viljanen","year":"1993","journal-title":"J Clin Microbiol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2013.12.007","article-title":"Genetic diversity and phylogeny of Mycobacterium avium","volume":"21","author":"Rindi","year":"2014","journal-title":"Infect Genet Evol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.meegid.2018.10.003","article-title":"Recent advances in molecular diagnostics and understanding mechanisms of drug resistance in nontuberculous mycobacterial diseases","volume":"72","author":"Huh","year":"2019","journal-title":"Infect Genet Evol"},{"key":"B91","article-title":"Laboratory detection and identification of mycobacteria","volume-title":"CLSI Standard: document M48","author":"Forbes","year":"2018"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.32.12.2995-2998.1994","article-title":"Use of Gen-Probe AccuProbes to identify Mycobacterium avium complex, Mycobacterium tuberculosis complex, Mycobacterium kansasii, and Mycobacterium gordonae directly from BACTEC TB broth cultures","volume":"32","author":"Reisner","year":"1994","journal-title":"J Clin Microbiol"},{"key":"B93","article-title":"Susceptibility testing of mycobacteria, Nocardiae, and other aerobic Actinomycetes","volume-title":"CLSI Standard: document M24","author":"Woods","year":"2018"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00834-19","article-title":"Antimycobacterial susceptibility testing of nontuberculous mycobacteria","volume":"57","author":"Brown-Elliott","year":"2019","journal-title":"J Clin Microbiol"},{"key":"B95","article-title":"Performance standards for susceptibility testing of mycobacteria, Nocardia spp., and other aerobic Actinomycetes","volume-title":"CLSI Standard: document M24S","author":"Parrish","year":"2023"},{"key":"B96","volume-title":"Sensititre\u2122 myco RAPMYCOI AST plate","year":""},{"key":"B97","volume-title":"Sensititre\u2122 myco SLOMYCOI AST plate","year":""},{"key":"B98","volume-title":"Anyplex\u2122 II. MTB\/NTM Real-Time Dectection","year":""},{"key":"B99","volume-title":"INNO-LiPA","year":""},{"key":"B100","volume-title":"GeNO","year":""},{"key":"B101","volume-title":"GeNO","year":""},{"key":"B102","volume-title":"Type Mycobacterium as Ver 1.0","year":""},{"key":"B103","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10156-006-0457-8","article-title":"Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates","volume":"12","author":"Kobashi","year":"2006","journal-title":"J Infect Chemother"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01240-16","article-title":"Clinical characteristics, treatment outcomes, and resistance mutations associated with macrolide-resistant Mycobacterium avium complex lung disease","volume":"60","author":"Moon","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"B105","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.1038\/s41598-021-85721-5","article-title":"Association between 16S rRNA gene mutations and susceptibility to amikacin in Mycobacterium avium Complex and Mycobacterium abscessus clinical isolates","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep"},{"key":"B106","doi-asserted-by":"publisher","first-page":"ii1","DOI":"10.1136\/thoraxjnl-2017-210927","article-title":"British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)","author":"Haworth","year":"2017","journal-title":"Thorax"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00586-7","article-title":"Consensus management recommendations for less common non-tuberculous mycobacterial pulmonary diseases","volume":"22","author":"Lange","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.10.048","article-title":"Impact of time between diagnosis and treatment for nontuberculous mycobacterial pulmonary disease on culture conversion and all-cause mortality","volume":"161","author":"Im","year":"2022","journal-title":"Chest"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01088-22","article-title":"Antibiotic maintenance and redevelopment of nontuberculous mycobacteria pulmonary disease after treatment of Mycobacterium avium complex pulmonary disease","volume":"10","author":"Zo","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00574-2020","article-title":"Nontuberculous mycobacterial pulmonary disease: an integrated approach beyond antibiotics","volume":"7","author":"Faverio","year":"2021","journal-title":"ERJ Open Res"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.10.031","article-title":"Managing Mycobacterium avium complex lung disease with a little help from my friend","volume":"159","author":"Griffith","year":"2021","journal-title":"Chest"},{"key":"B112","doi-asserted-by":"publisher","first-page":"210212","DOI":"10.1183\/16000617.0212-2021","article-title":"Management of Mycobacterium avium complex and Mycobacterium abscessus pulmonary disease: therapeutic advances and emerging treatments","volume":"31","author":"Kumar","year":"2022","journal-title":"Eur Respir Rev"},{"key":"B113","unstructured":"Guidance for treatment of non-tuberculous mycobacterial infection in patients with adult- onset immunodeficiency syndrome due to anti-interferon gamma autoantibody\n          \n          2023"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1086\/cid.1998.27.issue-5","article-title":"Randomized, open-label trial of azithromycin plus ethambutol vs. clarithromycin plus ethambutol as therapy for Mycobacterium avium complex bacteremia in patients with human immunodeficiency virus infection. Veterans Affairs HIV research consortium","volume":"27","author":"Ward","year":"1998","journal-title":"Clin Infect Dis"},{"key":"B115","unstructured":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV\n          \n          2020"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.3851\/IMP1455","article-title":"Effectiveness and safety of antiretrovirals with rifampicin: crucial issues for high-burden countries","volume":"14","author":"Maartens","year":"2009","journal-title":"Antivir Ther"},{"key":"B117","article-title":"Lack of association between plasma levels of non-nucleoside reverse transcriptase inhibitors & virological outcomes during rifampicin co-administration in HIV-infected TB patients","volume":"138","author":"Ramachandran","year":"2013","journal-title":"Indian J Med Res"},{"key":"B118","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13063-020-4132-7","article-title":"Pharmacokinetics, SAfety\/tolerability, and EFficacy of high-dose RIFampicin in tuberculosis-HIV co-infected patients on efavirenz- or dolutegravir-based antiretroviral therapy: study protocol for an open-label, phase II clinical trial (SAEFRIF)","volume":"21","author":"Nabisere","year":"2020","journal-title":"Trials"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000000944","article-title":"Critical review: What dose of rifabutin is recommended with antiretroviral therapy","volume":"72","author":"Yapa","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2018.04.001","article-title":"NTM drug discovery: status, gaps and the way forward","volume":"23","author":"Wu","year":"2018","journal-title":"Drug Discovery Today"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.638306","article-title":"Role of clofazimine in treatment of Mycobacterium avium complex","volume":"8","author":"Nasiri","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B122","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1378\/chest.14-2764","article-title":"Preliminary results of bedaquiline as salvage therapy for patients with nontuberculous mycobacterial lung disease","volume":"148","author":"Philley","year":"2015","journal-title":"Chest"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1071","article-title":"Model-based meta-analysis of rifampicin exposure and mortality in Indonesian tuberculous meningitis trials","volume":"71","author":"Svensson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"B124","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.crphar.2020.100007","article-title":"Tuberculosis and pharmacological interactions: A narrative review","volume":"2","author":"Riccardi","year":"2020","journal-title":"Curr Res Pharmacol Drug Discovery"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200509-1531OC","article-title":"Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease","volume":"173","author":"Lam","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"B126","article-title":"HIV medicine association of Infectious Disease Society of America panel and guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV \u2013 a working group of the Office of AIDS Research advisory Counsil (OARAC)","volume-title":"Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV","year":"2022"},{"key":"B127","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2466-7-2","article-title":"Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series","volume":"7","author":"Davis","year":"2007","journal-title":"BMC Pulm Med"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201307-231OC","article-title":"Inhaled amikacin for treatment of refractory pulmonary nontuberculous mycobacterial disease","volume":"11","author":"Olivier","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00011-18","article-title":"Amikacin inhalation as salvage therapy for refractory nontuberculous mycobacterial lung disease","volume":"62","author":"Jhun","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201604-0700OC","article-title":"Randomized trial of liposomal amikacin for inhalation in nontuberculous mycobacterial lung disease","volume":"195","author":"Olivier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1318OC","article-title":"Amikacin liposome inhalation suspension for treatment-refractory lung disease caused by Mycobacterium avium complex (CONVERT). A prospective, open-label, randomized study","volume":"198","author":"Griffith","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12890-022-02257-8","article-title":"Impact of initiation of amikacin liposome inhalation suspension on hospitalizations and other healthcare resource utilization measures: a retrospective cohort study in real-world settings","volume":"22","author":"Aksamit","year":"2022","journal-title":"BMC Pulm Med"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02087-16","article-title":"Emergence of mmpT5 variants during bedaquiline treatment of Mycobacterium intracellulare lung disease","volume":"55","author":"Alexander","year":"2017","journal-title":"J Clin Microbiol"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1900118","DOI":"10.1183\/13993003.00118-2019","article-title":"Failure with acquired resistance of an optimised bedaquiline-based treatment regimen for pulmonary Mycobacterium avium complex disease","volume":"54","author":"Zweijpfenning","year":"2019","journal-title":"Eur Respir J"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.3201\/eid2703.202359","article-title":"Bedaquiline as treatment for disseminated nontuberculous mycobacteria infection in 2 patients co-infected with HIV","volume":"27","author":"Gil","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00169114","article-title":"The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease","volume":"45","author":"Winthrop","year":"2015","journal-title":"Eur Respir J"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02281-12","article-title":"Treatment of refractory Mycobacterium avium complex lung disease with a moxifloxacin-containing regimen","volume":"57","author":"Koh","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01048-23","article-title":"Effects of bedaquiline combined with fluoroquinolone and\/or clofazimine on QT interval in patients with multidrug-resistant tuberculosis: a retrospective study","volume":"11","author":"Li","year":"2023","journal-title":"Microbiol Spectr"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25495","article-title":"ATP-sensitive potassium channelopathies: focus on insulin secretion","volume":"115","author":"Ashcroft","year":"2005","journal-title":"J Clin Invest"},{"key":"B140","unstructured":"Data from \u201cDrug-induced liver injury: premarketing clinical evaluation\n          \n          \n          \n          2024"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199902043400507","article-title":"Tuberculosis in patients with human immunodeficiency virus infection","volume":"340","author":"Havlir","year":"1999","journal-title":"N Engl J Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1177\/106002809703100915","article-title":"Management of drug interactions in patients with HIV","volume":"31","author":"Tseng","year":"1997","journal-title":"Ann Pharmacother"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1517\/17425255.2014.883379","article-title":"Clinically relevant drug-drug interactions between antiretrovirals and antifungals","volume":"10","author":"Vadlapatla","year":"2014","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1080\/17476348.2021.1887734","article-title":"A multidisciplinary approach to the management of nontuberculous mycobacterial lung disease: a clinical perspective","volume":"15","author":"Ali","year":"2021","journal-title":"Expert Rev Respir Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1554544\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T07:08:09Z","timestamp":1742368089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1554544\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":144,"alternative-id":["10.3389\/fimmu.2025.1554544"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1554544","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,19]]},"article-number":"1554544"}}